Trifecta Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Buy
791
+6
+0.8% +$2.22K 0.04% 87
2026
Q1
$212K Hold
785
0.03% 97
2025
Q4
$259K Buy
785
+86
+12% +$29.1K 0.04% 91
2025
Q3
$241K Sell
699
-9,661
-93% -$2.92M 0.04% 94
2025
Q2
$3.23M Buy
10,360
+481
+5% +$184K 0.54% 46
2025
Q1
$5.17M Sell
9,879
-61
-0.6% -$31.2K 1.08% 33
2024
Q4
$5.03M Sell
9,940
-112
-1% -$63.6K 0.99% 33
2024
Q3
$5.88M Buy
10,052
+4
+0% +$2.26K 1.23% 27
2024
Q2
$5.12M Buy
10,048
+106
+1% +$52K 1.13% 28
2024
Q1
$4.92M Buy
9,942
+420
+4% +$214K 1.2% 26
2023
Q4
$5.01M Buy
9,522
+176
+2% +$93.9K 1.39% 20
2023
Q3
$4.71M Buy
9,346
+252
+3% +$124K 1.51% 16
2023
Q2
$4.37M Buy
9,094
+335
+4% +$164K 1.41% 17
2023
Q1
$4.14M Buy
8,759
+162
+2% +$78.2K 1.46% 18
2022
Q4
$4.56M Buy
+8,597
New +$4.55M 1.82% 13

Other funds holding UNH

Trifecta Capital Advisors's UNH Position: Q2 2026 in Review

Trifecta Capital Advisors increased its UnitedHealth (UNH) stake by 0.76% in Q2 2026, buying an estimated $2.22K and bringing the position to 791 shares worth $329K. The position accounts for 0.04% of the portfolio, ranked #87.

Trifecta Capital Advisors first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.88M in Q3 2024. 3,386 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Trifecta Capital Advisors held 791 shares of UnitedHealth worth $329K as of Q2 2026.
  • Trifecta Capital Advisors bought 6 UnitedHealth shares in Q2 2026, an estimated $2.22K.
  • UnitedHealth made up 0.04% of Trifecta Capital Advisors's portfolio in Q2 2026, its #87 holding.
  • Trifecta Capital Advisors first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • Trifecta Capital Advisors's UnitedHealth position peaked at $5.88M in Q3 2024.
  • 3,386 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.